Careviso is a technology healthcare company helping to simplify and streamline patient access for molecular diagnostics.
Careviso has raised $17.0M in total funding. The most recent round was Series B. The last funding was announced in September 2022.
Careviso's investors include Mercury, Lytical Ventures, Signature Bank, Ballast Point Ventures.
Careviso is headquartered in Falls Church, United States.
Careviso is a technology healthcare company helping to simplify and streamline patient access for molecular diagnostics.
Careviso is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Careviso — Funding & Investors." VCBacked, September 28, 2022, https://www.vcbacked.co/company/careviso. Accessed September 30, 2026.
VCBacked. (2022). Careviso — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/careviso
{{cite web |title=Careviso — Funding & Investors |url=https://www.vcbacked.co/company/careviso |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated